Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
2.510
+0.170 (7.26%)
At close: Apr 28, 2026, 4:00 PM EDT
2.496
-0.014 (-0.57%)
After-hours: Apr 28, 2026, 7:19 PM EDT
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $230.62 million as of April 28, 2026. Its market cap has increased by 278.46% in one year.
Market Cap
230.62M
Enterprise Value
164.73M
1-Year Change
278.46%
Ranking
Category
Stock Price
$2.51
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $230.62M, an increase of 351.94%. That is a compound annual growth rate of 39.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 215.00M | 59.18% |
| Dec 31, 2025 | 135.06M | 43.39% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elicio Therapeutics | 215.05M |
| MediWound | 214.89M |
| Achieve Life Sciences | 214.02M |
| OmniAb | 211.38M |
| Enlivex | 210.91M |
| Nkarta | 208.17M |
| Caribou Biosciences | 205.84M |
| MacroGenics | 202.76M |